Kiniksa Pharmaceuticals International, plc (KNSA) Shareholders’ equity 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) shareholders’ equity at each fiscal year-end, per SEC filings.
$567.6MFY2025 · since FY2021: $185.0M → $567.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $567.6M | +29.5% |
| FY2024 | $438.4M | -0.1% |
| FY2023 | $438.8M | +10.8% |
| FY2022 | $396.1M | +114.1% |
| FY2021 | $185.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice